SCHEMBL16096641

SCHEMBL16096641

COCOc1ccncc1C=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ERN1 O75460 4/20 0.37
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA9 Q16790 2/20 0.36
CA14 Q9ULX7 1/20 0.36
MAPT P10636 1/20 0.35
BACE1 P56817 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP2E1 P05181 1/20 0.33
CYP2A6 P11509 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2B6 P20813 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3416435 0.87 ALDH1A1 (0.38) ALDH1A1HPGDHTTSMN1; SMN2ERN1
Ethane SCHEMBL28051940 0.85 ALDH1A1 (0.37) ALDH1A1HPGDHTTSMN1; SMN2ERN1
SCHEMBL17895679 0.83 CA12 (0.53) ALDH1A1HPGDHTTSMN1; SMN2CA12
SCHEMBL1605930 0.80 ERN1 (0.49) ALDH1A1ERN1CA12CA1CA2
SCHEMBL30937481 0.80 ERN1 (0.49) ALDH1A1ERN1CA12CA1CA2
SCHEMBL18995860 0.80 CYP2D6 (0.45) ALDH1A1HPGDHTTSMN1; SMN2CA12
SCHEMBL28267778 0.79 KDM1A (0.39) CA12CA1CA2CA9CA14
SCHEMBL14682168 0.78 ALDH1A1 (0.43) ALDH1A1HPGDHTTSMN1; SMN2ERN1
SCHEMBL7807057 0.77 ALDH1A1 (0.44) ALDH1A1HTTERN1MAPTBACE1
SCHEMBL1243967 0.75 ALDH1A1 (0.68) ALDH1A1HPGDHTTSMN1; SMN2ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970308-A1 COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN Global Blood Therapeutics, Inc. (US) 2016-01-20 EP disclosed
WO-2014150276-A1 COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN GLOBAL BLOOD THERAPEUTICS, INC. (US) 2014-09-25 WO disclosed